Cytochrome P450 gene

Abstract: A gene encoding a cytochrome P450 expressed specifically at initial stages in flower-bud growth and a promoter inducing expression of the gene are provided. The cytochrome P450 gene encodes the amino acid sequences encoded by the sequence having the nucleotide 1 to 1488 or the nucleotide 1 to 1617 in SEQ ID NO. 1, and the promoter consists of the base sequence within the nucleotide 1 to 1041 in SEQ ID NO. 4 that is necessary for the promoter activity.

Description: The present invention relates to plant-derived novel cytochrome P450 genes. The present invention further relates to a cytochrome P450-derived promoter which functions at initial stages of flower-bud formation. Flower buds are formed in a period when higher plants convert their growth from vegetative growth to reproductive growth. In this period, many genes express as the functions and forms of the plants change. It is therefore of significant importance to obtain a gene expressed specifically at initial stages of flower-bud formation and its promoter to provide a means for clarifying the mechanism of reproductive growth and for genetically engineering plants in their reproductive growth period. However, the mechanism of flower-bud formation has not been fully clarified, and, in particular, no gene that is involved in flower-bud formation or promoter that induces its expression are known. On the other hand, cytochrome P450 in higher plants is known as a gene which is involved in 1. secondary metabolism of flavonoids and alkaloids, and 2. metabolism of chemicals such as herbicides. Examples of cytochrome P450 involved in the secondary metabolism include cDNA for cinnamate 4-hydroxylase, flavonoid-3'-5'-hydroxylase, jasmonate synthase, and salicylate hydroxylase which have been cloned and are known to be concerned with biophylaxis, and biosynthesis and metabolism of phytohormones and signal substances. It is known that cytochrome P450 genes consist of many groups of genes called superfamily, and it is also known that the homology of amino acid sequences in a family equals to, or more than 40$ (Nebert et al. DNA Cell Biol. 10, 1-14, 1991). European patent application No. EP-A-522880 discloses genetic sequences encoding flavonoid pathway enzymes and uses therefore, particularly relating to a nucleic acid isolate comprising a sequence encoding a dehydrocampferol (DHK) hydroxylating enzyme or a derivative or part thereof. The invention also relates to transgenic plants carrying and expressing the above mentioned nucleic acid materials, and furthermore the 3'-5'-hydroxylase activity at different developmental stages in petunia flowers is determined. However, the document does not show that 3'-5'-hydroxylase activity was detected in stage 1 of the flower-bud formation. Hence, the 3'-5'-hydroxylase gene is expressed subsequent to the differentiation of various floral organs, such as petols, calxypistol and stanman, and is not expressed in the stages 1 and 2 of the flower-bud formation contrary to the present invention. No presence of a cytochrome P450 that specifically expresses at initial stages of flower-bud growth has been known heretofore. The present invention provides a cytochrome P450 expressed specifically at initial stages of flower-bud growth, a gene encoding the cytochrome P450, and a promoter which induces expression of the gene. FIG. 1 is a photograph in place of a drawing showing the stages of flower-bud growth. FIG. 2 shows a Northern blot analysis illustrating expression of M15 gene in each stage of the growth of flower-buds. FIG. 3 shows a Northern blot analysis illustrating expression of K40 gene in each stage of the growth of flower-buds. The inventors found in studies on the mechanism of flower-bud formation that there are some cytochrome P450 enzymes in petunia that express specifically at the initial stages of flower-bud formation. The gene of the present invention is a cytochrome P450 gene which expresses at the initial stages of flower-bud formation and that is obtained by cloning using Primer 1 (5'-AAAGAAACATTTCGAAAGCACCC) and/or Primer 2 (5'-AAATTCTTCGTCCAGCACCAAATGG). An example of the gene of the present invention is a cytochrome P450 gene encoding amino acid sequences encoded by the sequence having the nucleotide 1 to 1488 in SEQ ID NO: 1. Another example of the gene of the present invention is a cytochrome P450 gene encoding amino acid sequences encoded by the sequence having the nucleotide 1 to 1617 in SEQ ID NO: 3. The gene is a novel gene which belongs to a new family because its amino acid sequence has a 40% or lower sequence homology with amino acid sequences of known cytochrome P450, because its nucleotide sequence is different from the nucleotide sequences of any known cytochrome P450 genes, and because the site and time of its expression is specific. The gene of the present invention is readily obtained by those skilled in the art according to the disclosure of the present specification. Leaves or flower buds of petunia (preferably those in the initial stage of growth) may be used as materials for isolation of the gene. For instance, following the procedures described in examples below, mRNA is purified at first from flower buds in the initial stage of growth, and single stranded cDNA is prepared using a reverse transcriptase. Primers for PCR are synthesized based on the amino acid sequences in the vicinity of the heme binding region in known cytochrome P450 (D. R. Nelson, Cytochrom P450, 2nd ed., p575-606, 1995). PCR was performed using the single strand cDNA as a template. The resulting PCR products were sequenced at random to provide a cDNA clone containing a partial nucleotide sequence of the cytochrome P450 (e.g. M15 and K40 in the examples below). A Northern blot analysis was carried out using the cDNA clone as a probe to confirm that the gene contained in the clone is most strongly expressed in initial stages of flower-bud growth. mRNA is purified from tissues in initial stages of flower-bud growth to construct a cDNA library. Screening the cDNA library with the previously acquired cDNA clone containing a partial nucleotide sequence of the cytochrome P450 can provide a full-length cDNA clone (e.g. IMT-1 and IMT-2 in the examples below). The gene can be confirmed to be a cytochrome P450 gene by examining its sequence homology with known cytochrome P450 genes by comparing their nucleotide sequences, or by expressing the gene with a suitable expression vector in a suitable host, for example, yeast, then measuring the expressed protein with a reduced-type spectrum, a spectrum in the presence of carbon monoxide (Hideo Okawa, Saibo-Kogaku, 6, 72-78, 1987). The so-called reverse genetic methods, such as 1. introducing to a plant a binary vector which transcripts a gene in an antisense direction to inhibit expression of the gene and examine the phenotype of the plant, or 2. introducing to a plant a binary vector which transcripts a gene in a sense direction to excessively express the gene and examine the phenotype of the plant are widely used to investigate the function of the gene or the activity of the enzyme encoded by the gene. For example, the resulting IMT-1 gene or IMT-2 gene may be inserted downstream of 35S promoter in a sense or antisense direction into a vector to create a binary vector, and the binary vector may be introduced into Petunia hybrida (Surfinia purple, Suntory Ltd.). Transformation of petunia is easy, and is a widely accepted practice. Alternatively, the use of Petunia hybrida containing transposon dTphl provides a plant having an intended gene (e.g., IMT-1 or IMT-2) destroyed by transposon. An analysis of its phenotype allows us to know the function of the gene and the activity of the enzyme encoded by the gene (Koes, et al. Proceedings of the 4th International Congress of Plant Molecular Biology, 2071, 1994). At this point in time, the mechanism of the gene of the present invention to be expressed specifically at initial stages in flower-bud formation has not been fully clarified. However, it is presumed that a promoter naturally associating with the cytochrome P450 gene of the present invention may have a nature whereby it specifically induces expression at initial stages in flower-bud formation. Consequently, the present invention also provides a promoter which naturally associates with the cytochrome P450 gene described above. The promoter is contained in the nucleotide 1 to 452 in SEQ ID NO: 2 or in the nucleotide 1 to 1041 in SEQ ID NO: 4. It may be readily understood that the least necessary region as a promoter is somewhat shorter than this. A promoter modified by insertion, substitution or deletion may have the substantially same promoter activity. Such modification can be made, for example, by site specific mutagenesis or suitable restriction enzyme digestion. Thus, the present invention also includes sequences made by modifying the nucleotide 1 to 452 in SEQ ID NO: 2 or modifying the nucleotide 1 to 1041 in SEQ ID NO: 4 with one or more insertion, substitution and/or deletion, as far as they have the promoter activity. The promoter of the present invention is isolated generally together with the above-mentioned cytochrome P450 gene. For instance, the promoter can be obtained by cloning promoter sequences related to gene regulation of plasmids (e.g. IMT-1 or IMT-2) containing a full-length cytochrome P450 gene through the inverse PCR method. It was found that the resulting cytochrome P450 genes belong to new families. This invention clarifies the mechanism of flower-bud growth and enables the application of the cloned gene and its promoter in controlling flowering. In other words, the genes of the present invention are expected to affect the flowering time, the shape of a flower and so on in various ways by introducing the gene to an ornamental plant, because the genes express specifically at initial stages of flower-bud formation. The genes are introduced preferably functionally combined with the promoters of the present invention, but it is also possible to use another promoter or to use in combination other elements to control the expression as needed. Examples of the ornamental plant include rose, chrysanthemum, carnation, gerbera, petunia, torenia and verbena. The genes of the present invention are further expected to be used to preferably affect the quantity and time of harvesting crops by affecting the flowering of cultivated plants such as grains and fructificative plants. Examples of such plants include rice, wheat, barley, tomato and apple. It is believed to be possible to introduce the promoters of the present invention which are functionally combined with any desired genes into a plant and to express the genes at initial stages of flower-bud formation in a time-specific manner. Thus, it is possible to introduce the promoter into the ornamental plants and cultured plants such as those described above combined with various genes to affect, for example, color, size, shape, flowering time, flowering inhibition, etc. The genes can be introduced into a plant by transforming plant cells with a conventional method, e.g. a method using Agrobacterium tumefaciens. The plant cells containing the introduced genes can be selected using a suitable marker when the cells are transformed. The cells confirmed to have the intended gene introduced can be regenerated into plants. Methods are widely known for selecting plant strains which stably maintain the genotype of the introduced gene. See for example, S. C. Deroles, et al., Biotechnology of 0rnamental Plants, p87-119, 1997, which describes these techniques. Cytochromes P450, which express in initial stages in flower-bud formation like cytochromes P450 of the present invention and which have slightly different amino acid sequences or nucleotide sequences, may exist in plants other than petunia. These genes encoding cytochromes P450 can be isolated from plants by the methods described above. More readily, the genes may be isolated by creating cDNA libraries from mRNA extracted from flower buds of respective plants and screening by general methods using as a probe the sequence having the nucleotide 1 to 1488 in SEQ ID NO: 1 or a partial sequence consisting of at least 10 to 15 bases selected as needed therefrom. Therefore, the genes and promoters of the present invention include genes encoding the cytochrome P450 which hybridizes with the sequence having the nucleotide 1 to 1488 in SEQ ID NO: 1, the nucleotide 1 - 1617 in SEQ ID NO: 3, or a partial sequence consisting of at least 10 to 15 bases selected as needed therefrom and which express at initial stages in flower-bud formation in plants. Such hybridization can be carried out e.g. under stringent conditions including washing conditions of 6 X SSC at 50°C. The present invention further relates to cytochrome P450 which has the amino acid sequence of the amino acid sequence 1 to 496 in SEQ ID NO: 1. The protein can be extracted from petunia or other plants ' flower buds at initial stages of formation. It is also possible to obtain the protein by inserting the gene of the present invention into a suitable expression vector, transforming a suitable host such as E. coli with the vector, culturing the transformed host, and purifying the protein from the cells or extracts. The purified protein can be used for flower-bud formation and controlling the form of flowers, etc. The present invention provides a novel cytochrome P450 gene as well as a promoter thereof. The present invention has further enabled application of the cytochrome P450 gene and the promoter thereof for controlling plant flowering. The invention will be described more specifically by following examples, which are not intended to limit the scope of the invention. Example 1 Purification of mRNA Seeds of Petunia hybrida Vilm™ (Sakata Inx Corp.) were sown on a vermiculite soil, and were budded and grown at 25°C under 12-hour light and 12-hour dark conditions. After 100 days, flower-buds were sampled at different five stages of growth (see Fig. 1). mRNA was purified from 0.1 g of flower buds in each stage. QuickPrep Micro mRNA Purification Kit™ (Pharmacia) was used to purify mRNA following the manufacturer's recommended procedures. Example 2 Synthesis of Single Strand cDNA Single strand cDNA was synthesized using as templates about 100 ng of the mRNA from each stage of flower buds in Example 1. First-strand cDNA Synthesis Kit™ (Pharmacia) was used to synthesize cDNA following the manufacturer's recommended procedures. Example 3 Synthesis of Primers for PCR and the PCR Conduct First, Primers 1 and 2 were synthesized as primers for PCR. Recognition sites for restriction endonucleases were inserted to respective primers. The underlined show the recognition sites. The recognition sites are not limited to those shown here but use of other suitable recognition sites is allowed as needed. Next, PCR was conducted. The reaction was conducted in 50 µl of a reaction fluid containing 0.14 pg/ml of the template single stranded cDNA (a mixture of those from stages 1 to 5) given in Example 2, 10 pmol of Primer 1', 10 pmol of Primer 2 ' , 0.04 mM dNTP, 2.5 mM magnesium chloride, buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/µl of TaqDNA polimerase (Toyobo Co., Ltd.) The reaction mixture was maintained at 94°C for 5 minutes, then were cycled 30 times between 94°C for 1 minute, 40°C for 1 minute and 72°C for 3 minutes. Then it was kept at 4°C. The PCR products were separated by electrophoresis on 2% agarose gel, then DNA fragments of about 250 bp were collected, cleaved with Eco RI and Hind III, then were cloned into the Eco RI site and Hind III site of the pBluescript SK (+) (Stratagene) to introduce into E. coli JM109. Example 4 Analysis of PCR Products The E. coli JM109 prepared in Example 3 was transformed to give colonies, from which 40 colonies were picked out at random and cultured separately. Plasmid DNA was purified from each culture fluid, and the nucleotide sequence of the DNA was determined at random. This resulted in a clone (M15) which has a partial sequence of the cDNA of cytochrome P450. Example 5 Northern blot Analysis of Expression of M15 Gene Expression of M15 gene in each stage of flower-buds (Fig. 1) was detected using 32 P-labelled EcoRI-HindIII fragments of the M15 clone as a DNA probe. 0.3 µg of mRNA was used for the analysis. Fig. 2 shows the results. It was demonstrated from Fig. 2 that the maximum expression was obtained in stage 1. Example 6 Cloning cDNA for Cytochrome P450 expressed in Flower Buds A cDNA library was constructed from the mRNA which was expressed at the stage 1 in the flower-bud growth. The library was constructed using ZAP-cDNA Synthesis Kit™ (Stratagene) following the manufacturer's recommended procedures. The Gigapack II Plus™ (Stratagene) was used for packaging. About 300,000 cDNA clones were screened using 32 P-labelled EcoRI-HindIII fragments of the M15 clone as a probe. Seven positive clones were selected. One clone that has the longest insert fragment (hereinafter referred to as IMT-1) was selected and was subjected to sequence analysis of cDNA. This resulted in cDNA encoding a novel full-length cytochrome P450 (SEQ ID NO.1). It was found that the amino acid sequence of the cytochrome P450 has 37% homology with the amino acid sequence of petunia flavonoid-3'-5'-hydroxylase. Example 7 Preparation of Template Genome DNA for Inverse PCR (IPCR) Chromosome DNA was prepared from 0.5 g of petunia leaves using ISOPLANT™ (Nippon Gene). After completely digesting 1 µg of the chromosome DNA with Hinc II, a self ligation reaction was carried out using T4 DNA ligase to produce template genome DNA for IPCR. Example 8 Inverse PCR (IPCR) First, four different primers for IPCR were synthesized: and All the primers are positioned in the vicinity of the 5 ' end of IMT-1. Next, PCR amplification was performed twice. The first PCR amplification was conducted in 50 µl of a reaction mixture. The reaction mixture contained 10 ng/µl of the template genome for IPCR obtained in Example 7 as well as 10 pmol of B primer, 10 pmol of C primer, 0.04 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/µl of TaqDNA polimerase (Toyobo Co., Ltd.). The reaction mixture was maintained at 94°C for 5 minutes, then were cycled 30 times between 94°C for 1 minute, 55°C for 2 minutes and 72°C for 3 minutes. Then it was kept at 4°C. The second PCR amplification was conducted in 50 µl of a reaction mixture. The reaction mixture contained 0.1 ng/µl of the product from the first IPCR, 10 pmol of A primer, 10 pmol of D primer, 0.04 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/µl of TaqDNA polymerase (Toyobo Co., Ltd.). The reaction mixture was maintained at 94°C for 5 minutes, then were cycled 30 times between 94°C for 1 minute, 55°C for 2 minutes and 72°C for 3 minutes. Then it was kept at 4°C. Example 9 Cloning IPCR Products and DNA Sequence Determination The products from the second IPCR were separated on a 0.7% agarose gel, and a 1.2-kb DNA product was specifically amplified and cloned into pTBlue T-Vector™ (Novagen). The plasmid was used to transform E. coli JM109. Seven single clones were cultured and subjected to DNA sequence determination. The sequence of the promoter region of IMT-1 was determined. The gene sequence of the promoter region of IMT-1 is shown in SEQ ID NO: 2 of sequence listing. Example 10 PCR and Analysis of PCR Products PCR was further conducted using the PCR products obtained in Example 3. One nanogram of the PCR products and 70 pmol of each of primer 2' and primer 3 were reacted in 50 µl of a reaction mixture containing 0.2 mM dNTP, 2.5mM MgCl 2 , buffer for PCR (Toyobo Co., Ltd.), and 0.1 unit/ml of rTaqDNA polymerase (Toyobo Co., Ltd.). The reaction mixture was maintained at 94°C for 3 minutes, then were cycled 40 times between 94°C for 30 seconds, 50°C for 30 seconds and 72°C for 45 seconds. Then it was cooled to 4°C. The sequence of the primer 3 is shown below: The resulting PCR products were separated by electrophoresis on a 2% agarose gel, then the DNA fragments of approximately 200 bp were collected, cloned into the Xho I site and HindIII site of pBluescriptSK+ plasmid vector, and introduced into E. coli JM109. From the resulting transformed colonies, 22 clones were selected at random and their plasmids were extracted and sequenced. A clone (K40) which has the cDNA sequence of cytochrome P450 was obtained. Example 11 Northern blot Analysis showing Expression of K40 Gene Expression of K40 gene in each stage of flower-buds (Fig. 1) was detected using 32 P-labelled XhoI-HindIII fragments of the K40 clone as a DNA probe. 0.5 µg of mRNA was used for the analysis. Fig. 3 shows the results. It was demonstrated from Fig. 3 that the maximum expression was obtained in stage 2. Example 12 Cloning cDNA for Cytochrome P450 expressed in Flower Buds A cDNA library was constructed from the mRNA which expressed at stage 2 in the flower-bud growth. The library was constructed using ZAP-cDNA Synthesis Kit™ (Stratagene) following the manufacturer's recommended procedures. The Gigapack II Plus (Stratagene) was used for packaging. About 500,000 cDNA clones were screened using 32 P-labelled Xho II- Hind III fragments of the K40 clone as a probe. Ninety-three positive clones were selected. One clone that has the longest insert fragment was selected and was subjected to sequence analysis of cDNA. This resulted in cDNA (SEQ ID NO: 3) encoding a novel full-length cytochrome P450 (IMT-2). It was found that the amino acid sequence of the cytochrome P450 has 39% homology with the amino acid sequence of CYP71A1, a molecular species of cytochrome P450 from avocado. Example 13 Preparation of Template Genome DNA for IPCR Chromosome DNA was prepared from 0.5 g of petunia leaves using ISOPLANT™ (Nippon Gene). After completely digesting 1 µg of the DNA with XbaI, self ligation was performed using T4 DNA ligase to produce template genome DNA for IPCR. Example 14 IPCR In order to obtain the promoter of IMT-2, four different primers were synthesized: and All the primers are positioned in the vicinity of the 5 ' end of IMT-2. Next, PCR amplification was performed twice. The first PCR amplification was conducted in 50 µl of a reaction mixture. The reaction fluid contained 10 ng/µl of the template genome DNA for IPCR, 50 pmol of E primer, 50 pmol of F primer, as well as 0.2 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR™ (Expand High Fidelity PCR System™, Boehringer Mannheim), and 0.04 unit/µl of enzyme mixes (Expand High Fidelity PCR System, Boehringer Mannheim). The reaction mixture was maintained at 94°C for 5 minutes, then were cycled 30 times between 94°C for 1 minute, 60°C for 1 minute and 72°C for 3 minutes. Then it was kept at 4°C. The second PCR amplification was conducted in 50 µl of a reaction mixture. The reaction mixture contained 0.2 ng/µl of the product from the first IPCR, 50 pmol of G primer, 50 pmol of H primer, 0.2 mM of dNTP, 2.5 mM of magnesium chloride, buffer for PCR (Expand High Fidelity PCR System™, Boehringer Mannheim), and 0.04 unit/µl of enzyme mixes (Expand High Fidelity PCR System™, Boehringer Mannheim). The reaction mixes were maintained at 94°C for 5 minutes, then were cycled 30 times between 94°C for 1 minute, 60°C for 1 minute and 72°C for 3 minutes. Then it was kept at 4°C. Example 15 Cloning IPCR Products and DNA Nucleotide Sequence Determination The products from the second IPCR were nucleotide separated on a 0.7% agarose gel, and a 1.7-kb DNA product was specifically amplified and cloned into pT7Blue T-Vector™ (Novagen). The plasmid was used to transform E . coli JM109. Single clones were cultured and subjected to DNA nucleotide sequence determination. The sequence of the promoter region of IMT-2 was determined. The gene sequence of the promoter region of IMT-2 is shown in SEQ ID NO: 4. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Suntory Limited (B) STREET: 1-40,Dojimahama 2-chome (C) CITY: Osaka-shi (D) STATE: osaka (E) COUNTRY: japan (F) POSTAL CODE (ZIP): none (ii) TITLE OF INVENTION: cytochrome P450 gene (iii) NUMBER OF SEQUENCES: 6 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patent In Release #1.0, Version #1.30 (EPO) (v) CURRENT APPLICATION DATA: APPLICATION NUMBER: EP 98103716.1 (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: JP 47682/1997 (B) FILING DATE: 03-MAR-1997 (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: JP 253167/1997 (B) FILING DATE: 18-SEP-1997 (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1722 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS : (A) LENGTH: 452 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1761 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1041 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:

Claims: A cytochrome P450 gene having maximal expression in stages 1 and 2 of flower-bud formation as in Fig. 1, obtained by cloning using Primer 1 and/or primer A Cytochrome P450 gene encoding amino acid sequence encoded by the sequence having the nucleotide 1 to 1488 in SEQ ID No. 1 or a gene which hybridises with all or a part of the sequences having the nucleotides 1 to 1488 in SEQ ID No. 1 under stringent conditions and which encodes a protein having the same activity as the cytochrome P450 having maximal expression in stages 1 and 2 of flower-bud formation of petunia as in Fig. 1. 3. A Cytochrome P450 gene encoding amino acid sequence encoded by the sequence having the nucleotide 1 to 1617 in SEQ ID No. 3 or a gene which hybridises with all or a part of the sequences having the nucleotides 1 to 1617 in SEQ ID No. 3 under stringent conditions and which encodes a protein having the same activity as the cytochrome P450 having maximal expression in stages 1 and 2 of flower-bud formation of petunia as in Fig. 1. Proteins encoded by the genes according to any one of claims 1 to 3. A DNA which comprises a nucleotide sequence of SEQ ID No. 2 or SEQ ID No. 4, or a nucleotide sequence which hybridises with the nucleotide sequence of SEQ ID No. 2 or SEQ ID No. 4, said DNA having a maximal promoter activity at stages 1 and 2 of flower-bud formation of plants as in Fig. 1.

Inventors: IMAISHI HIROMASA, OHKAWA HIDEO, IMAISHI, HIROMASA, OHKAWA, HIDEO
Applicants: SUNTORY LTD, SUNTORY LIMITED
Application year: 1998
Main classification: C12N15
IPC codes: C12R1, C07K14, C12N15, C12N9, C12P21